Global Cold Chain Products Market For Plasma Fractionation Size By Type (Ultra-Low Temperature Freezer, Plasma Freezer, Temperature Monitoring Devices), By End-User (Blood Collection Centers And Blood Component Providers, Hospitals And Transfusion Centers), By Geographic Scope And Forecast

Cold Chain Products Market For Plasma Fractionation Size And Forecast

Cold Chain Products Market For Plasma Fractionation size was valued at USD 544.5 Million in 2021 and is projected to reach USD 809.1 Million by 2030, growing at a CAGR of 4.5% from 2023 to 2030.

The market for cold chain products is developing due to several causes, including rising zoonotic disease concerns, increased use of immunoglobulins and other plasma products in various therapeutic fields, and increased demand for pharmaceuticals produced from plasma. Due to the rising demand for plasma freezers and other cold chain products, as well as the adoption of cutting-edge cold storage equipment, the industry for cold chain products is anticipated to grow. The Global Cold Chain Products Market For Plasma Fractionation report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cold Chain Products Market For Plasma Fractionation Definition

Plasma fractionation is the process of separating the various blood plasma constituents, including proteins, immunoglobulins, clotting factors, and albumin, to produce distinct therapeutic products. Various medical illnesses, such as immunological disorders, bleeding disorders, and neurological ailments, are treated with these plasma-derived products. These plasma-derived products need precise temperature control and unique storage settings to preserve their efficacy and safety due to their fragile nature and potential biological activity.

Plasma fractionation products must be stored and transported in a temperature-controlled environment, which calls for the use of cold chain items including refrigerators, freezers, temperature-controlled containers, and transport systems. The Cold Chain Products Market For Plasma Fractionation is driven by factors such as the increasing demand for plasma-derived medicinal products, advancements in plasma fractionation technologies, and the growing need for cold chain infrastructure. The Cold Chain Products Market For Plasma Fractionation is driven by factors such as the increasing demand for plasma-derived medicinal products, advancements in plasma fractionation technologies, and the growing need for cold chain infrastructure. In terms of End users, the market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, clinical research laboratories, and others.

These end users have specific requirements for cold chain infrastructure to handle plasma fractionation products. Blood collection centers and blood component providers play a vital role in collecting and processing blood for plasma fractionation, making them significant customers in the market. Temperature monitoring devices and systems are also integral components of cold chain products, ensuring continuous monitoring and recording of temperature conditions to prevent temperature excursions and ensure compliance with regulatory guidelines. By utilizing cold chain products specifically designed for plasma fractionation, healthcare facilities, blood centers, and research laboratories can ensure the quality, safety, and efficacy of plasma-derived products, enabling effective treatment and therapy for patients with various medical conditions.

Global Cold Chain Products Market For Plasma Fractionation Overview

The increasing utilization of immunoglobulins and other plasma products across various therapeutic areas is a significant driver for the Cold Chain Products Market For Plasma Fractionation. Immunoglobulins, such as IgG, play a crucial role in the treatment of primary immunodeficiency disorders and a wide range of other medical conditions. The demand for plasma fractionation is driven by the increasing clinical utilization of immunoglobulins, and this trend is expected to continue growing. In high-income countries, the demand for plasma therapeutics, particularly immunoglobulins, has been on the rise. This increased demand can lead to the production of surplus quantities of other therapeutic proteins, such as albumin.

As a result, the Cold Chain Products Market For Plasma Fractionation experiences growth as the need for suitable storage equipment, including ultra-low temperature freezers and plasma freezers, becomes essential throughout the manufacturing and application process. These cold chain products ensure that immunoglobulins and other plasma products maintain their potency, efficacy, and quality by preserving them under controlled temperature conditions. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), impose strict guidelines for the storage and transportation of plasma fractionation products. These regulations ensure product safety, efficacy, and quality throughout the supply chain. Compliance with these regulations necessitates the use of cold chain products and solutions to maintain proper temperature control, resulting in the growth of the market.

Plasma freezers and refrigerators are essential for storing plasma-based therapies at the recommended temperatures to ensure their quality and efficacy. However, in many developing countries and even some resource-constrained settings, there is a scarcity of skilled personnel who are trained in the proper operation and maintenance of these specialized storage equipment. Insufficient infrastructure and lack of training among healthcare workers pose challenges in maintaining the cold chain for plasma-based therapies. Without proper expertise and knowledge, there is an increased risk of storage temperature deviations, which can compromise the effectiveness and safety of these therapies. Moreover, plasma-based therapies often have a short shelf life, making it even more critical to have well-maintained equipment and trained personnel for timely and appropriate storage.

However, Diseases such as hemophilia, immune deficiency disorders, and alpha-I antitrypsin deficiency are on the rise globally. These conditions often require plasma-derived products for treatment and management. The growing prevalence of these diseases fuels the demand for plasma fractionation centers to meet the increasing need for plasma-derived therapies. The constant evolution of cold chain technologies presents opportunities for market growth. Innovations in temperature monitoring, real-time tracking, and data management systems improve the efficiency and reliability of cold chain logistics.

Global Cold Chain Products Market For Plasma Fractionation Segmentation Analysis

The Global Cold Chain Products Market For Plasma Fractionation is segmented on the basis of Type, End-User, and Geography.

Cold Chain Products Market For Plasma Fractionation, By Type

• Ultra-low temperature freezer
• Plasma freezer
• Temperature monitoring devices
• Plasma contact shock freezer
• Blood transport boxes
• Ice-lined refrigerator
• Others

Based on Type, the market is segmented into Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others. The increasing demand for plasma-derived medicinal products, advancements in plasma fractionation technologies, and the growing need for cold chain infrastructure contribute to the dominance of the Ultra-low temperature freezer segment in the Cold Chain Products Market For Plasma Fractionation. Ultra-low temperature freezers provide the necessary storage conditions to preserve the integrity and efficacy of plasma-derived products over an extended period. As the demand for plasma-derived medicinal products increases, the need for ultra-low-temperature freezers rises accordingly.

Cold Chain Products Market For Plasma Fractionation, By End-User

• Blood collection centers & blood component providers
• Hospitals and transfusion centers
• Clinical research laboratories
• Others

Based on End-User, the market is segmented into Blood collection centers & blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others. Blood collection centers and blood component providers indeed hold a significant share and exhibit rapid growth in the Cold Chain Products Market For Plasma Fractionation. Blood collection centers and blood component providers play a crucial role in collecting and processing blood to obtain plasma for fractionation.

As the demand for plasma fractionation products rises, these entities require reliable cold chain products to store and transport plasma-derived products effectively. Blood collection centers and blood component providers play a crucial role in collecting and processing blood to obtain plasma for fractionation. As the demand for plasma fractionation products rises, these entities require reliable cold chain products to store and transport plasma-derived products effectively.

Cold Chain Products Market For Plasma Fractionation, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

On the basis of Geography, the Global Cold Chain Products Market For Plasma Fractionation is classified into North America, Europe, Asia Pacific, Latin America, and Middle East And Africa. The expansion of the plasma fractionation industry in Latin America is one factor in the region’s projected fastest-rising growth in the Cold Chain Products Market For Plasma Fractionation. Other factors include the region’s growing hospital population, the prevalence of chronic diseases, improvements in medical treatments, growing public awareness of plasma-based products, and the region’s rising hospital and hospital population. As healthcare providers in Latin America adopt these innovative treatments, the demand for cold chain products in the region rises.

Key Players

The “Global Cold Chain Products Market For Plasma Fractionation” study report will provide valuable insight with an emphasis on the global market. The major players in the market are B MEDICAL SYSTEMS, Blue Star Limited, Thermo Fisher Scientific, Godrej and Boyce Manufacturing Co. Ltd., Haeir Biomedical, Eppendorf Se, Avantor, Inc., LLC, Biolife Solutions Inc., Helmer Scientific Inc, Vestfrost Solutions, Jeio Tech Inc., Monnit Corporation, BERLINGER & CO. AG, Biotecno, EBAC CO. LTD., ENVIRO TECHNOLOGIES, WITHNELL SENSORS, and Zhejiang Heli Refrigeration Equipment Co. Ltd.

Our market analysis provides in-depth information on key players, including information on their financial statements, product portfolios, product benchmarking, and SWOT analyses. Along with market share research, important development strategies, recent advancements, and market ranking analysis of the aforementioned competitors globally are also included in the competitive landscape section.

Key Developments

• In January 2023, Haier Biomedical (China) purchased Suzhou Kangsheng (China) to add disposable laboratory plastic consumables to its product line, increase smart laboratory application solution scenarios, and quickly grow its footprint in the cryopreservation industry. applications for microorganisms and cell culture.
• In March 2023, Blue Star introduced a line of deep freezers with more storage and more chilling capacity. These freezers were produced at Blue Star’s brand-new, top-notch manufacturing facility in Wada.
• In March 2022, The Ultra-Low Freezer U201 from B Medical was granted the WHO PQS prequalification. This Ultra-Low Freezer is the first ever in the world to be prequalified by the WHO PQS.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.